Downfalls of the FDA Accelerated Approval Pathway – Stringent Controls Must be Invoked to Ensure Prompt Submission of Follow-Up Confirmatory Trial Data
May 1, 2014, 00:00
10.1016/j.jval.2014.03.569
https://www.valueinhealthjournal.com/article/S1098-3015(14)00620-2/fulltext
Title :
Downfalls of the FDA Accelerated Approval Pathway – Stringent Controls Must be Invoked to Ensure Prompt Submission of Follow-Up Confirmatory Trial Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00620-2&doi=10.1016/j.jval.2014.03.569
First page :
A98
Section Title :
Cancer
Open access? :
No
Section Order :
1621